Ikenna G. Madu
Kineta (United States)(US)Lyell Immunopharma (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, Ubiquitin and proteasome pathways, Hepatitis B Virus Studies, Viral Infections and Outbreaks Research
Most-Cited Works
- → Characterization of a Highly Conserved Domain within the Severe Acute Respiratory Syndrome Coronavirus Spike Protein S2 Domain with Characteristics of a Viral Fusion Peptide(2009)330 cited
- → Elastase-mediated Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein at Discrete Sites within the S2 Domain(2010)104 cited
- → Heparan Sulfate Is a Selective Attachment Factor for the Avian Coronavirus Infectious Bronchitis Virus Beaudette(2007)83 cited
- → SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion(2009)72 cited
- → Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design(2011)63 cited
- → A potent Lassa virus antiviral targets an arenavirus virulence determinant(2018)58 cited
- → Identification and Characterization of a New Chemotype of Noncovalent SENP Inhibitors(2013)43 cited
- → Lassa antiviral LHF-535 protects guinea pigs from lethal challenge(2022)15 cited
- → A Novel Class of HIV-1 Antiviral Agents Targeting HIV via a SUMOylation-Dependent Mechanism(2015)15 cited
- → Assays for Investigating deSUMOylation Enzymes(2012)10 cited